NCT00079846View on ClinicalTrials.gov

Implitapide in Patients With Homozygous Familial Hypercholesterolemia (HoFH) on Maximal Concurrent Lipid-Lowering Therapy

PHASE2TerminatedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

April 30, 2005

Conditions
Familial Hypercholesterolemia
Interventions
DRUG

Implitapide

Trial Locations (6)

45229

Metabolic and Atherosclerosis Research Center, Cincinnati

91120

Hadassah University Hospital, Jerusalem

G7H 5H6

Lipid Clinic and Community Genomic Center, Complexe Hospitalier de la Sagamie, Chicoutimi

G1V 4G2

Lipid Research Center, CHUL du CHUQ, Sainte-Foy

1105 AZ

Academic Medical Center Amsterdam, Amsterdam

N-0027

Lipidklinikken - Rikshospitalet, Oslo

Sponsors
All Listed Sponsors
lead

Medical Research Laboratories International

INDUSTRY